Amnestic Mild cognitive impairment
Conditions
Interventions
Verum acupuncture group:Acupuncture at Shenting, Baihui, Sanyinjiao, Taixi, Dazhong
Sham acupuncture group:Sham acupuncture
Sponsors
Chengdu University of Traditional Chinese Medicine; Affiliated hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: aMCI: 1. Must meet the criteria: memory complaints and meets criteria by Jak/Bondi diagnostic criteria (17) in 2014; 2. Are from 50 to 80 years of age, right-handed, and Mandarin-speaking; 3. Have the course of the disease for at least three months; 4. Have a dementia score on the Clinical Dementia Scale (CDR) score = 0.5; 5. Have an ischemia score on Hachinski Ischemic Score (HIS) score = 4; 6. Have at least eight years of education, and could understand and complete the scale correctly; 7. Have signed informed consent; 8. Have no contraindications for MRI. Health Control: 1. Aged between 50 and 80 years, right-handed, and Mandarin-speaking. 2. No objective cognitive impairment (non-subjective cognitive decline/MCI/dementia) as per the Jak/Bondi criteria, and normal daily living abilities (a Functional Activities Questionnaire [FAQ] score <9). 3. No MRI contraindications. 4. Good compliance and willingness to participate, including signing an informed consent form.
Exclusion criteria
Exclusion criteria: aMCI: 1. In a treatment course that may interfere with cognitive function; 2. Other neurological disorders that may cause cognitive impairment (except for potential early Alzheimer's disease) include vascular dementia, Parkinson's disease, brain tumors, brain trauma leading to neurological impairment, and other brain structural abnormalities. Other systemic disorders that may bring about cognitive decline (anemia, metabolic encephalopathy, Hashimoto encephalopathy, etc.; 3. Brain MRI suggesting infection or other local lesions, multiple embolic infarctions, infarction in vital memory brain areas, or severe white matter lesions (Fazekas score = 3); 4. With tumor, psychiatric history (such as bipolar disorder, schizophrenia, severe anxiety (Hamilton Anxiety Scale (HAMA) = 29), and major depression (Hamilton Depression Scale (HAMD) = 24) according to DSM - V diagnostic criteria; 5. With bleeding tendency, hemorrhagic disease, or severe skin infection; 6. Severe drug dependence, smoking, drug, and alcohol abuse; 7. In a pregnant, lactation, or childbearing period; 8. In other clinical investigators within six months. Health Control: 1. Claustrophobia. 2. Significant cranial anatomical asymmetry or definite pathological findings in MRI. 3. Currently participating in other clinical studies.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alzheimer's Disease Assessment Scale - Cognitive; | — |
Secondary
| Measure | Time frame |
|---|---|
| Montreal Cognitive Assessment-Basic;Shape Trails Test-A&B;Animal Fluency Test;Boston Naming Test;Digital Span Test;Symbol Digit Modalities Test;Clock Drawing Test;Functional Activities Questionnaire;Hamilton Anxiety Scale;Hamilton Depression Scale;Pittsburgh Sleep Quality Index;Magnetic Resonance Imaging;Auditory Verbal Learning Test ; | — |
Countries
China
Contacts
Public ContactFanrong Liang
Chengdu University of Traditional Chinese Medicine; Affiliated hospital of Chengdu University of Traditional Chinese Medicine
Outcome results
None listed